Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
4(21%)
Results Posted
23%(3 trials)
Terminated
1(5%)

Phase Distribution

Ph early_phase_1
2
11%
Ph not_applicable
5
26%
Ph phase_3
1
5%
Ph phase_4
1
5%
Ph phase_2
2
11%

Phase Distribution

2

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
2(18.2%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

4

trials recruiting

Total Trials

19

all time

Status Distribution
Active(5)
Completed(13)
Terminated(1)

Detailed Status

Completed13
Recruiting3
Active, not recruiting1
Terminated1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
4
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (18.2%)
Phase 22 (18.2%)
Phase 31 (9.1%)
Phase 41 (9.1%)
N/A5 (45.5%)

Trials by Status

active_not_recruiting15%
terminated15%
enrolling_by_invitation15%
recruiting316%
completed1368%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT06925295Phase 2

Using Xe MRI to Guide Radiation Therapy for Lung Cancer

Recruiting
NCT01851642

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

Recruiting
NCT05976919

Evaluating Treatable Traits Across the Spectrum of Chronic Obstructive Airways Disease

Recruiting
NCT03072849

Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation

Completed
NCT05609201

PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT

Enrolling By Invitation
NCT03468101

Characterization of Professional COPD Related to Exposure to Organic Dust - Mean Follow up at 6 Years

Terminated
NCT04519320Not Applicable

Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae

Active Not Recruiting
NCT04773184

Improving Diagnostic Standards in Dysphagia

Completed
NCT02962050

Delineating Swallowing Impairment and Decline in ALS

Completed
NCT03696758Phase 2

Improving Right Ventricular Function in Young Adults Born Preterm

Completed
NCT00914147Not Applicable

Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors

Completed
NCT03245723Not Applicable

Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI)

Completed
NCT03068091Not Applicable

Assessment of Lung Movement With Computed Tomography (CT)

Completed
NCT02710110Early Phase 1

Respiratory Strength Training in Persons With Amyotrophic Lateral Sclerosis (ALS)

Completed
NCT01820117

Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

Completed
NCT02710162Early Phase 1

Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)

Completed
NCT01155115Not Applicable

Inflammatory and Microbiologic Markers in Sputum: Comparing Cystic Fibrosis With Primary Ciliary Dyskinesia

Completed
NCT00239408Phase 4

Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

Completed
NCT00246623Phase 3

US Inhaled Insulin Dose Titration Study

Completed

All 19 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
19